07/31/2024 3:10 PM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2024 3:15 PM | Sage Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024 5:39 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2024 3:57 PM | Federer Jessica (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:57 PM | Barrett Elizabeth (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:57 PM | COLA MICHAEL F (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:58 PM | FRATES JAMES M (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/11/2024 3:58 PM | Germano Geno J (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:58 PM | Golumbeski George (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:58 PM | JONAS JEFFREY M (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 5:45 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 11:15 AM | Sage Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
06/10/2024 8:48 AM | FMR LLC (Filed by) Sage Therapeutics (Subject)
| Form SC 13G/A | |
06/06/2024 8:54 AM | Sage Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
04/25/2024 6:15 AM | Sage Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024 5:46 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2024 3:07 PM | Sage Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024 3:10 PM | Sage Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024 3:13 PM | Sage Therapeutics (Filer)
| Form ARS | |
04/19/2024 7:31 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/17/2024 5:35 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2024 7:34 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 6:49 AM | Sage Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024 6:20 AM | Sage Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 6:09 AM | RTW INVESTMENTS, LP (Filed by) Sage Therapeutics (Subject)
| Form SC 13G | |
02/14/2024 5:45 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 4:13 PM | Sage Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/13/2024 5:28 AM | Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024 5:28 AM | BB BIOTECH AG (Filed by) BB BIOTECH AG (Filed by) Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 8:49 AM | FMR LLC (Filed by) Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024 9:17 AM | Sage Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/31/2024 4:25 PM | Sage Therapeutics (Subject)
| Form SC TO-I/A | |
01/31/2024 3:50 PM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2024 9:04 AM | Sage Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024 7:13 AM | Sage Therapeutics (Subject)
| Form SC TO-I | |
01/08/2024 5:45 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:07 PM | IGUCHI KIMI (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | Golumbeski George (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | FRATES JAMES M (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | PAUL STEVEN M (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | Federer Jessica (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9460&Placement=NativeDisplay&Source=NativeDisplay) Learn more about this much-needed advancement and investment opportunity here. |
12/19/2023 7:30 AM | Sage Therapeutics (Filer)
| Form DEF 14A | |
12/19/2023 7:32 AM | Sage Therapeutics (Filer)
| Form DEFA14A | |
12/08/2023 8:00 AM | Sage Therapeutics (Subject)
| Form SC TO-C | |
12/08/2023 7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
12/08/2023 7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
11/07/2023 6:39 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 6:29 AM | Sage Therapeutics (Filer)
| Form 424B5 | |
11/07/2023 6:00 AM | Sage Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 5:46 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |